{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:51:29Z","timestamp":1790484689814,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00428-020-02795-8","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T04:05:31Z","timestamp":1584331531000},"page":"535-544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy"],"prefix":"10.1007","volume":"477","author":[{"given":"J. O. A. M.","family":"van Baal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A. R.","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. S.","family":"Jordanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Horlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. J.","family":"van Driel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. C.","family":"Amant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. K.","family":"Van de Vijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,16]]},"reference":[{"issue":"1","key":"2795_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tice.2016.11.004","volume":"49","author":"JO van Baal","year":"2017","unstructured":"van Baal JO, Van de Vijver KK, Nieuwland R, van Noorden CJ et al (2017) The histophysiology and pathophysiology of the peritoneum. Tissue Cell 49(1):95\u2013105. https:\/\/doi.org\/10.1016\/j.tice.2016.11.004","journal-title":"Tissue Cell"},{"key":"2795_CR2","first-page":"41","volume":"177","author":"PJ Knudsen","year":"1991","unstructured":"Knudsen PJ (1991) The peritoneal elastic lamina. J Anat 177:41\u201346","journal-title":"J Anat"},{"issue":"7","key":"2795_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1097\/DCR.0000000000000124","volume":"57","author":"M Yokota","year":"2014","unstructured":"Yokota M, Kojima M, Nomura S, Nishizawa Y, Kobayashi A, Ito M, Ochiai A, Saito N (2014) Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III. Dis Colon Rectum 57(7):830\u2013838. https:\/\/doi.org\/10.1097\/DCR.0000000000000124","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"2795_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10350-003-0083-9","volume":"47","author":"E Shinto","year":"2004","unstructured":"Shinto E, Ueno H, Hashiguchi Y, Hase K, Tsuda H, Matsubara O, Mochizuki H (2004) The subserosal elastic lamina: an anatomic landmark for stratifying pT3 colorectal cancer. Dis Colon Rectum 47(4):467\u2013473. https:\/\/doi.org\/10.1007\/s10350-003-0083-9","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"2795_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/path.4002","volume":"227","author":"DA Leinster","year":"2012","unstructured":"Leinster DA, Kulbe H, Everitt G, Thompson R, Perretti M, Gavins FN, Cooper D, Gould D, Ennis DP, Lockley M, McNeish I, Nourshargh S, Balkwill FR (2012) The peritoneal tumour microenvironment of high-grade serous ovarian cancer. J Pathol 227(2):136\u2013145. https:\/\/doi.org\/10.1002\/path.4002","journal-title":"J Pathol"},{"issue":"3","key":"2795_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348(3):203\u2013213. https:\/\/doi.org\/10.1056\/NEJMoa020177","journal-title":"N Engl J Med"},{"issue":"3","key":"2795_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/modpathol.2008.191","volume":"22","author":"B Clarke","year":"2009","unstructured":"Clarke B, Tinker AV, Lee CH, Subramanian S, van de Rijn M, Turbin D, Kalloger S, Han G, Ceballos K, Cadungog MG, Huntsman DG, Coukos G, Gilks CB (2009) Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss. Mod Pathol 22(3):393\u2013402. https:\/\/doi.org\/10.1038\/modpathol.2008.191","journal-title":"Mod Pathol"},{"issue":"7","key":"2795_CR8","doi-asserted-by":"publisher","first-page":"e6412","DOI":"10.1371\/journal.pone.0006412","volume":"4","author":"K Milne","year":"2009","unstructured":"Milne K, Kobel M, Kalloger SE, Barnes RO et al (2009) Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS One 4(7):e6412. https:\/\/doi.org\/10.1371\/journal.pone.0006412","journal-title":"PLoS One"},{"issue":"3","key":"2795_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.7785\/tcrt.2012.500312","volume":"12","author":"C Lan","year":"2013","unstructured":"Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T, Lu J, Liu J (2013) Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol Cancer Res Treat 12(3):259\u2013267. https:\/\/doi.org\/10.7785\/tcrt.2012.500312","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"2795_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ijc.28335","volume":"134","author":"S Reinartz","year":"2014","unstructured":"Reinartz S, Schumann T, Finkernagel F, Wortmann A, Jansen JM, Meissner W, Krause M, Schw\u00f6rer AM, Wagner U, M\u00fcller-Br\u00fcsselbach S, M\u00fcller R (2014) Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse. Int J Cancer 134(1):32\u201342. https:\/\/doi.org\/10.1002\/ijc.28335","journal-title":"Int J Cancer"},{"issue":"6","key":"2795_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","volume":"24","author":"S Hendry","year":"2017","unstructured":"Hendry S, Salgado R, Gevaert T, Russell PA et al (2017) Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors. Adv Anat Pathol 24(6):311\u2013335. https:\/\/doi.org\/10.1097\/PAP.0000000000000161","journal-title":"Adv Anat Pathol"},{"issue":"5","key":"2795_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/PAP.0000000000000162","volume":"24","author":"S Hendry","year":"2017","unstructured":"Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, van den Eynden G, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de Wind R, Curigliano G, Andr\u00e9 F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB (2017) Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international Immunooncology biomarkers working group: part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research. Adv Anat Pathol 24(5):235\u2013251. https:\/\/doi.org\/10.1097\/PAP.0000000000000162","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"2795_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","volume":"21","author":"GJ Rustin","year":"2011","unstructured":"Rustin GJ, Vergote I, Eisenhauer E, Pujade-Lauraine E, Quinn M, Thigpen T, du Bois A, Kristensen G, Jakobsen A, Sagae S, Greven K, Parmar M, Friedlander M, Cervantes A, Vermorken J, Gynecological Cancer Intergroup (2011) Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the gynecological Cancer intergroup (GCIG). Int J Gynecol Cancer 21(2):419\u2013423. https:\/\/doi.org\/10.1097\/IGC.0b013e3182070f17","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"2795_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ygyno.2018.06.015","volume":"150","author":"BL Manning-Geist","year":"2018","unstructured":"Manning-Geist BL, Hicks-Courant K, Gockley AA, Clark RM, del Carmen M, Growdon WB, Horowitz NS, Berkowitz RS, Muto MG, Worley MJ Jr (2018) Moving beyond \"complete surgical resection\" and \"optimal\": is low-volume residual disease another option for primary debulking surgery? Gynecol Oncol 150(2):233\u2013238. https:\/\/doi.org\/10.1016\/j.ygyno.2018.06.015","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2795_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","volume":"103","author":"DS Chi","year":"2006","unstructured":"Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, Sonoda Y, Levine DA, Hensley M, Barakat RR (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103(2):559\u2013564. https:\/\/doi.org\/10.1016\/j.ygyno.2006.03.051","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2795_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","volume":"130","author":"SJ Chang","year":"2013","unstructured":"Chang SJ, Hodeib M, Chang J, Bristow RE (2013) Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis. Gynecol Oncol 130(3):493\u2013498. https:\/\/doi.org\/10.1016\/j.ygyno.2013.05.040","journal-title":"Gynecol Oncol"},{"issue":"12","key":"2795_CR17","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1016\/j.humpath.2013.07.013","volume":"44","author":"A Grin","year":"2013","unstructured":"Grin A, Messenger DE, Cook M, O'Connor BI, Hafezi S, el-Zimaity H, Kirsch R (2013) Peritoneal elastic lamina invasion: limitations in its use as a prognostic marker in stage II colorectal cancer. Hum Pathol 44(12):2696\u20132705. https:\/\/doi.org\/10.1016\/j.humpath.2013.07.013","journal-title":"Hum Pathol"},{"issue":"9","key":"2795_CR18","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1097\/PAS.0b013e3181ecfe98","volume":"34","author":"M Kojima","year":"2010","unstructured":"Kojima M, Nakajima K, Ishii G, Saito N, Ochiai A (2010) Peritoneal elastic laminal invasion of colorectal cancer: the diagnostic utility and clinicopathologic relationship. Am J Surg Pathol 34(9):1351\u20131360. https:\/\/doi.org\/10.1097\/PAS.0b013e3181ecfe98","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2795_CR19","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1097\/PAS.0b013e31828ea2de","volume":"37","author":"WY Liang","year":"2013","unstructured":"Liang WY, Chang WC, Hsu CY, Arnason T, Berger D, Hawkins AT, Sylla P, Lauwers GY (2013) Retrospective evaluation of elastic stain in the assessment of serosal invasion of pT3N0 colorectal cancers. Am J Surg Pathol 37(10):1565\u20131570. https:\/\/doi.org\/10.1097\/PAS.0b013e31828ea2de","journal-title":"Am J Surg Pathol"},{"key":"2795_CR20","doi-asserted-by":"publisher","unstructured":"Liang WY, Wang YC, Hsu CY, Yang SH (2018) Staging of colorectal cancers based on elastic Lamina invasion. Hum Pathol. https:\/\/doi.org\/10.1016\/j.humpath.2018.10.019","DOI":"10.1016\/j.humpath.2018.10.019"},{"issue":"4","key":"2795_CR21","doi-asserted-by":"publisher","first-page":"e0194804","DOI":"10.1371\/journal.pone.0194804","volume":"13","author":"J Lu","year":"2018","unstructured":"Lu J, Hu X, Meng Y, Zhao H, Cao Q, Jin M (2018) The prognosis significance and application value of peritoneal elastic lamina invasion in colon cancer. PLoS One 13(4):e0194804. https:\/\/doi.org\/10.1371\/journal.pone.0194804","journal-title":"PLoS One"},{"issue":"6024","key":"2795_CR22","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331(6024):1565\u20131570. https:\/\/doi.org\/10.1126\/science.1203486","journal-title":"Science"},{"issue":"4","key":"2795_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pages F, Sautes-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12(4):298\u2013306. https:\/\/doi.org\/10.1038\/nrc3245","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2795_CR24","doi-asserted-by":"publisher","first-page":"15621","DOI":"10.18632\/oncotarget.14919","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Wang J, Chen R, Bai Y et al (2017) The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer. Oncotarget 8(9):15621\u201315631. https:\/\/doi.org\/10.18632\/oncotarget.14919","journal-title":"Oncotarget"},{"issue":"3","key":"2795_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/annonc\/mdw625","volume":"28","author":"SJL Mesnage","year":"2017","unstructured":"Mesnage SJL, Auguste A, Genestie C, Dunant A, Pain E, Drusch F, Gouy S, Morice P, Bentivegna E, Lhomme C, Pautier P, Michels J, le Formal A, Cheaib B, Adam J, Leary AF (2017) Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC). Ann Oncol 28(3):651\u2013657. https:\/\/doi.org\/10.1093\/annonc\/mdw625","journal-title":"Ann Oncol"},{"issue":"4","key":"2795_CR26","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1158\/1078-0432.CCR-16-1433","volume":"23","author":"CS Lo","year":"2017","unstructured":"Lo CS, Sanii S, Kroeger DR, Milne K, Talhouk A, Chiu DS, Rahimi K, Shaw PA, Clarke BA, Nelson BH (2017) Neoadjuvant chemotherapy of ovarian Cancer results in three patterns of tumor-infiltrating lymphocyte response with distinct implications for immunotherapy. Clin Cancer Res 23(4):925\u2013934. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1433","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2795_CR27","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1158\/1078-0432.CCR-15-2657","volume":"22","author":"S Bohm","year":"2016","unstructured":"Bohm S, Montfort A, Pearce OM, Topping J et al (2016) Neoadjuvant chemotherapy modulates the immune microenvironment in metastases of Tubo-ovarian high-grade serous carcinoma. Clin Cancer Res 22(12):3025\u20133036. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2657","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2795_CR28","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00262-010-0817-1","volume":"59","author":"M Polcher","year":"2010","unstructured":"Polcher M, Braun M, Friedrichs N, Rudlowski C et al (2010) Foxp3(+) cell infiltration and granzyme B(+)\/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma. Cancer Immunol Immunother 59(6):909\u2013919. https:\/\/doi.org\/10.1007\/s00262-010-0817-1","journal-title":"Cancer Immunol Immunother"},{"issue":"23","key":"2795_CR29","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1158\/0008-5472.CAN-14-3098","volume":"75","author":"J Peng","year":"2015","unstructured":"Peng J, Hamanishi J, Matsumura N, Abiko K, Murat K, Baba T, Yamaguchi K, Horikawa N, Hosoe Y, Murphy SK, Konishi I, Mandai M (2015) Chemotherapy induces programmed cell death-ligand 1 overexpression via the nuclear factor-kappaB to Foster an immunosuppressive tumor microenvironment in ovarian Cancer. Cancer Res 75(23):5034\u20135045. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3098","journal-title":"Cancer Res"},{"issue":"7528","key":"2795_CR30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, Seja E, Cherry G, Gutierrez AJ, Grogan TR, Mateus C, Tomasic G, Glaspy JA, Emerson RO, Robins H, Pierce RH, Elashoff DA, Robert C, Ribas A (2014) PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515(7528):568\u2013571. https:\/\/doi.org\/10.1038\/nature13954","journal-title":"Nature"},{"issue":"5","key":"2795_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00428-012-1232-0","volume":"460","author":"JP Vayrynen","year":"2012","unstructured":"Vayrynen JP, Vornanen JO, Sajanti S, Bohm JP et al (2012) An improved image analysis method for cell counting lends credibility to the prognostic significance of T cells in colorectal cancer. Virchows Arch 460(5):455\u2013465. https:\/\/doi.org\/10.1007\/s00428-012-1232-0","journal-title":"Virchows Arch"},{"issue":"25","key":"2795_CR32","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMoa051424","volume":"353","author":"F Pages","year":"2005","unstructured":"Pages F, Berger A, Camus M, Sanchez-Cabo F et al (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353(25):2654\u20132666. https:\/\/doi.org\/10.1056\/NEJMoa051424","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1007\/s00428-020-02974-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000}}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02795-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-020-02795-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02795-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T20:47:16Z","timestamp":1615841236000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-020-02795-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["2795"],"URL":"https:\/\/doi.org\/10.1007\/s00428-020-02795-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,16]]},"assertion":[{"value":"27 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A correction to this paper has been published: <ExternalRef><RefSource>https:\/\/doi.org\/10.1007\/s00428-020-02974-7<\/RefSource><RefTarget Address=\"10.1007\/s00428-020-02974-7\" TargetType=\"DOI\"\/><\/ExternalRef>","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the Institutional Review Board of the NKI-AVL (PTC15.0324\/M14BBB).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}